Clover Health Investments (CLOV) Revenue (2020 - 2026)

Clover Health Investments has reported Revenue for 7 years, with the latest figure at $744.2 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 60.96% year-over-year to $744.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 48.29% YoY), and the FY2025 full-year result was $1.9 billion, up 37.97% from the prior year.
• Revenue for Q1 2026 stood at $744.2 million, up from $485.9 million in the prior quarter.
• The five-year high for Revenue was $856.8 million in Q3 2022, with the low at -$1.5 billion in Q4 2022.
• Historically, Revenue has averaged $305.5 million across 5 years, with a median of $337.0 million in 2024.
• The largest YoY upside for Revenue was 320.72% in 2022 against a maximum downside of 445.58% in 2022.
• Clover Health Investments' Revenue stood at -$1.5 billion in 2022, then jumped by 120.92% to $312.4 million in 2023, then rose by 7.87% to $337.0 million in 2024, then surged by 44.19% to $485.9 million in 2025, then jumped by 53.17% to $744.2 million in 2026.
• The last three Revenue figures came in at $744.2 million (Q1 2026), $485.9 million (Q4 2025), and $496.6 million (Q3 2025), per Business Quant data.